Law, Politics, and Expert Panels at the US Food and Drug Administration

JAMA Health Forum 2026 Open access

Read full text
Authors: C. Joseph Ross Daval, Aaron S. Kesselheim
DOI: 10.1001/jamahealthforum.2025.6812
Cited by: 1
References: 6

Abstract

This Viewpoint discusses the lawfulness and credibility of the US Food and Drug Administration’s recent move to using expert panels rather than advisory committees for decision-making.

Fields of Study & Subjects

Ethics in Clinical Research Pharmaceutical industry and healthcare Education Healthcare and Sociology Research

Publication details

Journal / source
JAMA Health Forum
Publisher
American Medical Association (AMA)
Volume
7
Issue
2
Pages
e256812–e256812
Publication date
13 February 2026
Language
EN